Zubieta-Rodríguez R, Gómez-Correa J, Rodríguez-Amaya R, Ariza-Mejia K A, Toloza-Cuta N A
Escuela de Medicina, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia.
Escuela de Medicina, Facultad de Salud, Universidad Industrial de Santander, Bucaramanga, Santander, Colombia.
Rev Gastroenterol Mex. 2017 Jul-Sep;82(3):203-209. doi: 10.1016/j.rgmx.2016.10.002. Epub 2017 Apr 19.
Cirrhosis of the liver is known for its high risk of mortality associated with episodes of acute decompensation. There is an even greater risk in patients that present with acute-on-chronic liver failure. The identification of patients at higher risk for adverse outcomes can aid in making the clinical decisions that will improve the prognosis for these patients.
To determine in-hospital mortality and evaluate the epidemiologic and clinical characteristics of patients with cirrhosis of the liver seen at a tertiary referral hospital.
A descriptive, observational, cohort study was conducted on adult patients with cirrhosis of the liver, admitted to a tertiary care center in Bucaramanga, Colombia, within the time frame of March 1, 2015 and February 29, 2016.
Eighty-one patients with a mean age of 62 years were included in the study. The main etiology of the cirrhosis was alcoholic (59.3%). In-hospital mortality was 23.5% and the most frequent cause of death was septic shock (68.4%), followed by hypovolemic shock (10.5%). A MELD score≥18, a leukocyte count>12,000/ul, and albumin levels below<2.5g/dl were independent factors related to hospital mortality.
In-hospital mortality in cirrhotic patients is high. Sepsis and bleeding are the 2 events leading to acute-on-chronic liver failure and death. A high MELD score, elevated leukocyte count, and low level of albumin are related to poor outcome during hospitalization. Adjusted prevention-centered public health measures and early and opportune diagnosis of this disease are needed to prevent the development of complications and to improve outcome in cirrhotic patients.
肝硬化因与急性失代偿发作相关的高死亡率而闻名。对于患有慢加急性肝衰竭的患者,风险甚至更高。识别出不良结局风险较高的患者有助于做出改善这些患者预后的临床决策。
确定在一家三级转诊医院就诊的肝硬化患者的院内死亡率,并评估其流行病学和临床特征。
对2015年3月1日至2016年2月29日期间入住哥伦比亚布卡拉曼加一家三级护理中心的成年肝硬化患者进行了一项描述性、观察性队列研究。
81名平均年龄为62岁的患者纳入研究。肝硬化的主要病因是酒精性(59.3%)。院内死亡率为23.5%,最常见的死亡原因是感染性休克(68.4%),其次是低血容量性休克(10.5%)。终末期肝病模型(MELD)评分≥18、白细胞计数>12,000/ul以及白蛋白水平低于<2.5g/dl是与医院死亡率相关的独立因素。
肝硬化患者的院内死亡率很高。脓毒症和出血是导致慢加急性肝衰竭和死亡的两个事件。高MELD评分、白细胞计数升高和低白蛋白水平与住院期间的不良结局相关。需要采取以预防为中心的公共卫生措施以及对该疾病进行早期和适时诊断,以预防并发症的发生并改善肝硬化患者的结局。